Table 6 Subgroup analysis of patients with CPAK phenotype changed from types 4–9 to types 1–3 with those who remained consistently in types 1–3
Changed CPAK phenotype changed from types 4–9 to types 1–3 (n = 10) | Same CPAK in types 1–3 (n = 103) | p value (95% CI) | |
|---|---|---|---|
Mean ± SD | |||
KSFS 0 weeks | 46.0 ± 24.1 | 58.5 ± 18.5 | 0.050 (0.02, 25.0) |
KSS 0 weeks | 59.8 ± 16.3 | 56.0 ± 20.5 | 0.550 (− 16.5, 8.8) |
KSFS 6 weeks | 50.5 ± 22.4 | 49.6 ± 26.1 | 0.913 (− 18.1, 16.2) |
KSS 6 weeks | 86.6 ± 10.4 | 85.7 ± 12.1 | 0.816 (− 8.9, 7.0) |
KSFS 3 months | 59.4 ± 15.9 | 63.6 ± 22.7 | 0.615 (− 12.3, 20.7) |
KSS 3 months | 91.6 ± 9.1 | 88.9 ± 10.2 | 0.499 (− 10.7, 5.2) |
KSFS 6 months | 72.7 ± 13.3 | 72.5 ± 18.7 | 0.969 (− 11.7, 11.3) |
KSS 6 months | 90.2 ± 16.0 | 92.3 ± 8.8 | 0.495 (− 4.0, 8.3) |
KSFS 12 months | 66.4 ± 19.1 | 78.9 ± 17.0 | 0.024 (1.7, 23.5) |
KSS 12 months | 92.8 ± 9.4 | 93.9 ± 7.23 | 0.636 (− 3.6, 5.8) |